Armstrong Advisory Group’s Healthpeak Properties DOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.43K Buy
+222
New +$4.71K ﹤0.01% 812
2026
Q2
– Sell
-810
Closed -$13.3K – 991
2026
Q1
$13.3K Hold
810
– – ﹤0.01% 637
2025
Q4
$13K Hold
810
– – ﹤0.01% 633
2025
Q3
$15.5K Hold
810
– – ﹤0.01% 603
2025
Q2
$14.2K Hold
810
– – ﹤0.01% 599
2025
Q1
$16.4K Hold
810
– – ﹤0.01% 558
2024
Q4
$16.4K Hold
810
– – ﹤0.01% 558
2024
Q3
$18.5K Hold
810
– – ﹤0.01% 521
2024
Q2
$15.9K Hold
810
– – ﹤0.01% 530
2024
Q1
$16K Hold
810
– – ﹤0.01% 511
2023
Q4
$16K Hold
810
– – ﹤0.01% 511
2023
Q3
$14.9K Hold
810
– – ﹤0.01% 541
2023
Q2
$16.3K Hold
810
– – ﹤0.01% 524
2023
Q1
$17.8K Hold
810
– – ﹤0.01% 498
2022
Q4
$20.3K Buy
+810
New +$19.7K ﹤0.01% 486

Other funds holding DOC

Armstrong Advisory Group's DOC Position: Q3 2026 in Review

Armstrong Advisory Group opened a new position in Healthpeak Properties (DOC) in Q3 2026: 222 shares worth $4.43K. The stake represents ﹤0.01% of the portfolio and ranks #812 among its holdings. This is a return to the name: Armstrong Advisory Group previously reported a position in DOC as recently as Q1 2026.

Armstrong Advisory Group first reported a position in DOC in Q4 2022 and has held it in 15 quarters since. The position peaked at $20.3K in Q4 2022. 763 funds tracked by Wall St. Rank hold DOC as of Q3 2026.

  • Armstrong Advisory Group held 222 shares of Healthpeak Properties worth $4.43K as of Q3 2026.
  • Healthpeak Properties was a new Armstrong Advisory Group position in Q3 2026.
  • Healthpeak Properties made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q3 2026, its #812 holding.
  • Armstrong Advisory Group first reported a position in Healthpeak Properties in Q4 2022 and has held it in 15 quarters since.
  • Armstrong Advisory Group's Healthpeak Properties position peaked at $20.3K in Q4 2022.
  • 763 funds tracked by Wall St. Rank held Healthpeak Properties as of Q3 2026.

Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.